FindTrial
Sign In

Randomized controlled study of hepatic venous deprivation for induction of liver regeneration in stage hepatectomy

Randomized controlled study of hepatic venous deprivation for induction of liver regeneration in stage hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014624
Enrollment
Unknown
Registered
2018-01-24
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver malignant tumor

Interventions

Intervention group:LVD
Control group:ALPPS

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients' aged betwwen 18-60 years old; 2. Diagnosed with liver malignant tumor (hepatocellular caicinoma, cholangiocarcinoma colorectal liver metastasis et al); 3. Child-pugh A or B, estimated survival time moren 6 months; 4. Reveive right hemihepatectomy ot extended right hemihepatectomy; 5. Future remnant liver volume < 40% of total liver volume; 6. No portal venin thrombosis, and no extrahepatic metastasis.

Exclusion criteria

Exclusion criteria: 1. Cardiopulmonary dysfunction; 2. HIV infection; 3. Refractory ascites; 4. Encephalopathy; 5. Renal insufficiency.

Design outcomes

Primary

MeasureTime frame
future remnant liver enlarging speed and volume;resection of hepatic segment, manner and duration of hepatic blood flow occlusion, amount of bleeding, blood transfusion, dispose of hepatic cross section;—

Secondary

MeasureTime frame
Liver function, renal function, blood coagulation function, blood routine;1,3,5 year overall survival;—

Countries

China

Contacts

Public ContactWusheng Lu

West China Hospital, Sichuan University

luwu8@126.com+86 18980601482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026